| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
SOCS1 |
| 2 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
SOCS1 |
| 3 |
34714908 |
10.1182/bloodadvances.2021005486 |
2022 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. |
SOCS1 |
| 4 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
SOCS1 |
| 5 |
34854137 |
10.1111/ejh.13730 |
2022 |
Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphoma. |
SOCS1 |
| 6 |
35075971 |
10.1080/10428194.2021.2010060 |
2022 |
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. |
SOCS1 |
| 7 |
35205765 |
10.3390/cancers14041018 |
2022 |
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. |
SOCS1 |
| 8 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
SOCS1 |
| 9 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
SOCS1 |
| 10 |
35790291 |
10.21873/anticanres.15823 |
2022 |
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study. |
SOCS1 |
| 11 |
35879731 |
10.1186/s40364-022-00401-4 |
2022 |
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma. |
SOCS1 |
| 12 |
35885481 |
10.3390/diagnostics12071575 |
2022 |
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. |
SOCS1 |
| 13 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
SOCS1 |
| 14 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
SOCS1 |
| 15 |
33223115 |
10.1016/j.jep.2020.113514 |
2021 |
Ethyl acetate extract of Tibetan medicine Rhamnella gilgitica ameliorated type II collagen-induced arthritis in rats via regulating JAK-STAT signaling pathway. |
SOCS1 |
| 16 |
33684939 |
10.1182/blood.2020007683 |
2021 |
Characterization of DLBCL with a PMBL gene expression signature. |
SOCS1 |
| 17 |
33714214 |
10.1111/ejh.13620 |
2021 |
A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1. |
SOCS1 |
| 18 |
33899787 |
10.1097/PAS.0000000000001691 |
2021 |
The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma. |
SOCS1 |
| 19 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
SOCS1 |
| 20 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
SOCS1 |
| 21 |
34248938 |
10.3389/fimmu.2021.650977 |
2021 |
T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses <i>In Vivo</i>. |
SOCS1 |
| 22 |
34272731 |
10.1111/bjh.17708 |
2021 |
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. |
SOCS1 |
| 23 |
34312841 |
10.1111/bjh.17719 |
2021 |
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. |
SOCS1 |
| 24 |
34362488 |
10.19746/j.cnki.issn.1009-2137.2021.04.013 |
2021 |
[Second-generation Sequencing Analysis of Ph<sup>+</sup> and Ph-like Childhood T-cell Acute Lymphoblastic Leukemia]. |
SOCS1 |
| 25 |
34405005 |
10.7150/jca.60390 |
2021 |
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. |
SOCS1 |
| 26 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
SOCS1 |
| 27 |
31431735 |
10.1038/s41375-019-0541-6 |
2020 |
Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. |
SOCS1 |
| 28 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
SOCS1 |
| 29 |
31774495 |
10.1182/blood.2019001904 |
2020 |
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. |
SOCS1 |
| 30 |
31948699 |
10.1016/j.annpat.2019.12.006 |
2020 |
[Low-grade dural extranodal marginal zone lymphoma]. |
SOCS1 |
| 31 |
32187361 |
10.1182/blood.2019003535 |
2020 |
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. |
SOCS1 |
| 32 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
SOCS1 |
| 33 |
32495891 |
10.26355/eurrev_202005_21342 |
2020 |
Gene polymorphisms of SOCS1 and SOCS2 and acute lymphoblastic leukemia. |
SOCS1 |
| 34 |
32555149 |
10.1038/s41408-020-0335-0 |
2020 |
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. |
SOCS1 |
| 35 |
32947237 |
10.1016/j.tranon.2020.100855 |
2020 |
Identification of clinical molecular targets for childhood Burkitt lymphoma. |
SOCS1 |
| 36 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
SOCS1 |
| 37 |
33225311 |
10.1158/2643-3230.BCD-20-0051 |
2020 |
Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. |
SOCS1 |
| 38 |
29911923 |
10.1080/10428194.2018.1461861 |
2019 |
MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia. |
SOCS1 |
| 39 |
30211726 |
10.1097/PAS.0000000000001154 |
2019 |
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. |
SOCS1 |
| 40 |
30213827 |
10.3324/haematol.2018.203224 |
2019 |
<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. |
SOCS1 |
| 41 |
30972748 |
10.1002/jcp.28410 |
2019 |
microRNA-30a inhibits the liver cell proliferation and promotes cell apoptosis through the JAK/STAT signaling pathway by targeting SOCS-1 in rats with sepsis. |
SOCS1 |
| 42 |
31101761 |
10.1158/0008-5472.CAN-18-1503 |
2019 |
Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis. |
SOCS1 |
| 43 |
31305266 |
10.1097/PAS.0000000000001324 |
2019 |
Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With Hodgkin/Reed-Sternberg-like Cells of NK Phenotype. |
SOCS1 |
| 44 |
31407320 |
10.1111/bjh.16147 |
2019 |
The impact of SOCS1 mutations in diffuse large B-cell lymphoma. |
SOCS1 |
| 45 |
31515941 |
10.15252/emmm.201910576 |
2019 |
The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma. |
SOCS1 |
| 46 |
27859003 |
10.1111/bjh.14431 |
2018 |
Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A. |
SOCS1 |
| 47 |
29415891 |
10.1172/jci.insight.98368 |
2018 |
Efficacy of intracellular immune checkpoint-silenced DC vaccine. |
SOCS1 |
| 48 |
29650799 |
10.1182/blood-2017-11-814913 |
2018 |
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. |
SOCS1 |
| 49 |
30054295 |
10.1182/blood-2018-01-829424 |
2018 |
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. |
SOCS1 |
| 50 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
SOCS1 |
| 51 |
30144205 |
10.1002/gcc.22679 |
2018 |
Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides. |
SOCS1 |
| 52 |
30463380 |
10.3390/cancers10110459 |
2018 |
Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma. |
SOCS1 |
| 53 |
28082443 |
10.1182/blood-2016-06-720516 |
2017 |
A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells. |
SOCS1 |
| 54 |
28295300 |
10.1002/eji.201646806 |
2017 |
IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life. |
SOCS1 |
| 55 |
28302137 |
10.1186/s13045-017-0438-7 |
2017 |
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort. |
SOCS1 |
| 56 |
28424246 |
10.1084/jem.20160894 |
2017 |
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. |
SOCS1 |
| 57 |
28739740 |
10.21873/anticanres.11841 |
2017 |
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis. |
SOCS1 |
| 58 |
28866095 |
10.1016/j.canlet.2017.08.034 |
2017 |
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. |
SOCS1 |
| 59 |
26462859 |
10.1111/cei.12732 |
2016 |
Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma? |
SOCS1 |
| 60 |
26820519 |
10.1016/j.jconrel.2016.01.042 |
2016 |
A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells. |
SOCS1 |
| 61 |
26885984 |
10.1007/s11010-016-2665-6 |
2016 |
Response of the JAK-STAT pathway to mammalian hibernation in 13-lined ground squirrel striated muscle. |
SOCS1 |
| 62 |
27144517 |
10.18632/oncotarget.9077 |
2016 |
Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma. |
SOCS1 |
| 63 |
27198204 |
10.1038/leu.2016.135 |
2016 |
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. |
SOCS1 |
| 64 |
27356265 |
10.1002/gcc.22391 |
2016 |
Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas. |
SOCS1 |
| 65 |
25820993 |
10.1002/path.4539 |
2015 |
Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation. |
SOCS1 |
| 66 |
26336985 |
10.18632/oncotarget.4829 |
2015 |
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma. |
SOCS1 |
| 67 |
26599546 |
10.1371/journal.pone.0139663 |
2015 |
Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines. |
SOCS1 |
| 68 |
26633718 |
10.1038/cddis.2015.342 |
2015 |
Socs1 and Socs3 degrades Traf6 via polyubiquitination in LPS-induced acute necrotizing pancreatitis. |
SOCS1 |
| 69 |
24641245 |
10.1111/bjd.12717 |
2014 |
A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides. |
SOCS1 |
| 70 |
22488585 |
10.1002/hon.2010 |
2013 |
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma. |
SOCS1 |
| 71 |
23246696 |
10.1016/j.gene.2012.12.009 |
2013 |
Regulation of the MIR155 host gene in physiological and pathological processes. |
SOCS1 |
| 72 |
23296022 |
10.18632/oncotarget.774 |
2013 |
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients. |
SOCS1 |
| 73 |
23768868 |
10.1016/j.leukres.2013.05.003 |
2013 |
Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma. |
SOCS1 |
| 74 |
22387553 |
10.4049/jimmunol.1102899 |
2012 |
Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. |
SOCS1 |
| 75 |
21291295 |
10.3109/08820139.2010.534218 |
2011 |
Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma. |
SOCS1 |
| 76 |
21418178 |
10.1111/j.1365-2141.2011.08632.x |
2011 |
Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph). |
SOCS1 |
| 77 |
22000024 |
10.1016/j.smim.2011.09.001 |
2011 |
The role of the transcription factor Miz-1 in lymphocyte development and lymphomagenesis-Binding Myc makes the difference. |
SOCS1 |
| 78 |
20438785 |
10.1016/j.humimm.2010.04.004 |
2010 |
Polymorphisms in innate immunity genes and risk of childhood leukemia. |
SOCS1 |
| 79 |
19734449 |
10.1182/blood-2009-06-225839 |
2009 |
Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. |
SOCS1 |
| 80 |
18401415 |
10.1038/leu.2008.85 |
2008 |
STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma. |
SOCS1 |
| 81 |
18416826 |
10.1186/1471-2407-8-106 |
2008 |
Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. |
SOCS1 |
| 82 |
17652621 |
10.1182/blood-2007-03-082511 |
2007 |
Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. |
SOCS1 |
| 83 |
17764563 |
10.1186/1471-2164-8-302 |
2007 |
Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia. |
SOCS1 |
| 84 |
17934639 |
10.1590/s0100-879x2007001100003 |
2007 |
miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. |
SOCS1 |
| 85 |
16125365 |
10.1016/j.cellsig.2005.07.013 |
2006 |
Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS). |
SOCS1 |
| 86 |
16206268 |
10.1002/ijc.21539 |
2006 |
Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells. |
SOCS1 |
| 87 |
16287070 |
10.1002/ijc.21485 |
2006 |
Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein. |
SOCS1 |
| 88 |
16532038 |
10.1038/sj.onc.1209151 |
2006 |
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. |
SOCS1 |
| 89 |
16598306 |
10.1038/sj.leu.2404206 |
2006 |
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. |
SOCS1 |
| 90 |
16782810 |
10.1073/pnas.0603728103 |
2006 |
Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development. |
SOCS1 |
| 91 |
17169806 |
10.1080/10428190600948048 |
2006 |
The investigation of mutation and single nucleotide polymorphism of receptor tyrosine kinases and downstream scaffold molecules in acute myeloid leukemia. |
SOCS1 |
| 92 |
17867599 |
|
2006 |
[Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation]. |
SOCS1 |
| 93 |
15572583 |
10.1182/blood-2004-09-3701 |
2005 |
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. |
SOCS1 |
| 94 |
15580314 |
10.1038/sj.onc.1208032 |
2005 |
Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors. |
SOCS1 |
| 95 |
15815722 |
10.1038/sj.leu.2403741 |
2005 |
Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays. |
SOCS1 |
| 96 |
18035697 |
|
2005 |
[Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line]. |
SOCS1 |
| 97 |
14551136 |
10.1182/blood-2003-07-2617 |
2004 |
A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. |
SOCS1 |
| 98 |
14614518 |
10.1038/sj.leu.2403216 |
2004 |
SOCS1 and SHP1 hypermethylation in mantle cell lymphoma and follicular lymphoma: implications for epigenetic activation of the Jak/STAT pathway. |
SOCS1 |
| 99 |
14630083 |
10.1016/s0145-2126(03)00158-9 |
2004 |
Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells. |
SOCS1 |
| 100 |
14968112 |
10.1038/sj.onc.1207398 |
2004 |
Identification of NPM-ALK interacting proteins by tandem mass spectrometry. |
SOCS1 |
Datasets
Models
